Author

B. Vergier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:protein folding & dynamics· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1

Frequent Co-Authors

D. Cluet· 2 shared I. Amri· 2 shared M. Spichty· 2 shared A. Abou-Ammoud· 1 shared A. Jabouille· 1 shared A. Pham-Ledart· 1 shared A. Thurman· 1 shared A. Uguen· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

D. Cluet

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma

J. H. Raymond, M. Schonau, V. Petit, Z. Aktary, F. Luciani, M. Wehbe, I. Davidson, C.-L. Tomasetto, F. Mahuteau-Betzer, B. Vergier, L. Larue, V. Delmas

This study identifies an E-cadherin-ER-GRPR axis that drives sex-specific melanoma metastasis and shows GRPR inhibition reduces metastasis in vivo.

bioRxiv · Dec 2, 2022 · PreprintCancer Biology

Discoidin domain receptor 2 drives melanoma drug resistance through AXL-dependent phenotype switching

M. Sala, N. Allain, A. Jabouille, E. Henriet, A. Abou-Ammoud, A. Uguen, S. Di-Tommaso, D. Cyril, A.-A. Raymond, J.-W. Dupuy, E. Gerard, N. Dugot-Senant, B. Rousseau, J.-P. Merlio, A. Pham-Ledart, , F. Saltel

This study shows DDR2 drives melanoma drug resistance via AXL-dependent phenotype switching, suggesting DDR inhibition as a potential second-line treatment.

bioRxiv · Mar 26, 2021 · PreprintCancer Biology

Titration of in-cellula affinities of protein-protein interactions

D. Cluet, B. Vergier, N.-P. Levy, L. Dehau, A. Thurman, I. Amri, M. Spichty

The paper introduces a genetic assay using flow cytometry to quantify protein-protein interaction affinities at the single-cell level and demonstrates its application across diverse interactions.

bioRxiv · Apr 27, 2020 · PreprintBiochemistry

A quantitative tri-fluorescent yeast two-hybrid system: from flow cytometry to in-cellula affinities

D. Cluet, I. Amri, B. Vergier, J. Leault, C. Grosjean, D. Calabresi, M. Spichty

This paper introduces a quantitative yeast two-hybrid system using fluorescent proteins and flow cytometry to measure PPI affinities in living cells.

bioRxiv · Feb 18, 2019Biochemistry